GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Live Verdure Ltd (ASX:LV1) » Definitions » EBIT

Live Verdure (ASX:LV1) EBIT : A$-6.37 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Live Verdure EBIT?

Live Verdure's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was A$-4.91 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-6.37 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Live Verdure's annualized ROC % for the quarter that ended in Dec. 2023 was -752.23%. Live Verdure's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -4,013.91%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Live Verdure's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -11.60%.

Live Verdure EBIT Historical Data

The historical data trend for Live Verdure's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Live Verdure EBIT Chart

Live Verdure Annual Data
Trend Jun20 Jun21 Jun22 Jun23
EBIT
- -3.23 -3.11 -2.71

Live Verdure Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBIT Get a 7-Day Free Trial -2.01 -1.09 -1.25 -1.46 -4.91

Competitive Comparison of Live Verdure's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Live Verdure's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Live Verdure's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Live Verdure's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Live Verdure's EV-to-EBIT falls into.


Live Verdure EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-6.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Live Verdure  (ASX:LV1) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Live Verdure's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-10.298 * ( 1 - 0% )/( (1.312 + 1.426)/ 2 )
=-10.298/1.369
=-752.23 %

where

Invested Capital(Q: Jun. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2.493 - 1.142 - ( 0.169 - max(0, 1.228 - 1.267+0.169))
=1.312

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.131 - 0.422 - ( 1.283 - max(0, 0.467 - 2.145+1.283))
=1.426

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Live Verdure's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-9.814/( ( (0.051 + max(-0.126, 0)) + (0.021 + max(0.417, 0)) )/ 2 )
=-9.814/( ( 0.051 + 0.438 )/ 2 )
=-9.814/0.2445
=-4,013.91 %

where Working Capital is:

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.089 + 0.92 + 0.049) - (1.142 + 0 + 0.042)
=-0.126

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.101 + 0.643 + 0.118) - (0.422 + 0 + 0.023)
=0.417

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Live Verdure's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-6.369/54.924
=-11.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Live Verdure EBIT Related Terms

Thank you for viewing the detailed overview of Live Verdure's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Live Verdure (ASX:LV1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Live Verdure Ltd (ASX:LV1) » Definitions » EBIT
Comparable Companies
ASX:LGP ASX:CAN ASX:IVX ASX:ANP ASX:EOF ASX:ECS ASX:IDT ASX:PXS ASX:NXS ASX:AGH ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
459 Collins Street, Level 21, Melbourne, VIC, AUS, 3000
Website
http://www.liveverdure.com.au
Live Verdure Ltd is an Australian Health, Wellness and Skincare company making a range of naturally-based products with effective active ingredients. Its products are predominantly sold Direct-to-Consumer (D2C), using the Company's websites. The Company is engaged in providing hemp-based products under 13 seeds brand name. The company focuses on development of Australian hemp food, beauty and nutraceutical products.

Live Verdure (ASX:LV1) Headlines

No Headlines